Anti-Malarial Drug Market Size , share and growth with top key players GlaxoSmithKline Plc, Ranbaxy Laboratories, Zydus Cadila, Alvizia Health Care, Bayer AG, Pfizer, Inc., Ipca Laboratories Ltd, Merck KGaA, F. Hoffmann-La Roche AG, and Novartis AG

The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), and increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market.

Anti-malarial drugs are medications used for the treatment and prevention of malaria infection. They are also known as anti-malarials. These drugs are used for routine intermittent treatment of specific groups in endemic regions. Anti-malarial drugs are also used for prevention of infection in individuals who travel or visit a malaria-endemic region. Efficacious antimalarial therapy not only reduces the morbidity and mortality of malaria, but also reduces the risk of resistance to antimalarial drugs.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-toc-and-sample/2760

By geography, this market is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub segment of the market.

Key Benefits:

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.

• It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

• Extensive analysis by product elucidates the use of anti-malarial drugs in medical settings.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/2760

The global antimalarial drug market is segmented on the basis of drug type, malaria type, mechanism of action, distribution channel, and geography. Based on drug type, it is divided into quinine, chloroquine, pyrimethamine, amodiaquine, proguanil, mefloquine, sulfonamide, artemisinin & derivatives, atovaquone, primaquine, halofantrine, doxycycline, and clindamycin. On the malaria type, it is classified into plasmodium falciparum, plasmodium vivax, plasmodium malariae and plasmodium ovale. By mechanism of action, it is bifurcated into resistance and prevention. Furthermore, by distribution channel the antimalarial drug market is categorized into hospital pharmacy, retail pharmacy, e-commerce, and others.

Top key players in the market :

• GlaxoSmithKline Plc
• Ranbaxy Laboratories
• Zydus Cadila
• Alvizia Health Care
• Bayer AG
• Pfizer Inc.
• Ipca Laboratories Ltd
• Merck KGaA
• F. Hoffmann-La Roche AG
• Novartis AG

Anti-malarial Drug Market Key Segments:

By Drug Type

• Quinine
• Chloroquine
• Pyrimethamine
• Amodiaquine
• Proguanil
• Mefloquine
• Sulfonamide
• Artemisinin & Derivatives
• Atovaquone
• Primaquine
• Halofantrine
• Doxycycline
• Clindamycin

By Malaria Type
• Plasmodium Falciparum
• Plasmodium Vivax
• Plasmodium Malariae
• Plasmodium Ovale

By Mechanism of Action
• Resistance
• Prevention

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce
• Others

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/anti-malarial-drug-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.